References
- World Health Organisation. Programme Advisory Group. Report of the eighth meeting of the WHO programme advisory group on the prevention of blindness. World Health Organisation, Geneva 1989, WHO publication 89.17
- World Health Organisation. Management of cataract in primary health care services. World Health Organisation, Geneva 1990
- Health Insurance Commission. 1994, Unpublished dataCanberra
- Dever GEA. Epidemiology in health services management. Aspen, Gaithersburg, MD 1984
- Klein B EK, Klein R, Linton K LP. Prevalence of age-related lens opacities in a population. The Beaver Dam eye study. Ophthalmology 1992; 99: 546–52
- Hyman L. Epidemiology of eye disease in the elderly. Eye 1987; 1: 330–41
- Ederer F. Methodological problems in eye disease epidemiology. Epidemiol Rev 1983; 5: 51–66
- Dawson C R, Schwab I R. Epidemiology of cataract - a major cause of preventable blindness. Bull WHO 1981; 59(4)493–501
- Taylor A. Associations between nutrition and cataract. Nutr Rev 1989; 47: 225–34
- Rink H. Cataractogenic risk factors. Dev Ophthalmol 1987; 15: 66–76
- Klein B EK, Klein R, Linton K LP, Magli Y L, Neider M W. Assessment of cataracts from photographs in the Beaver Dam eye study. Ophthalmology 1990; 97: 1428–33
- Taylor H R., West S K, Rosenthal F S, Munoz B, Newland H S, Abbey H, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988; 319: 1429–33
- West S K, Rosenthal F, Newland Taylor H. HR. Use of photographic techniques to grade nuclear cataracts. Invest Ophthalmol Vis Sci 1988; 29(1)73–7
- West S K, Taylor H R. The detection and grading of cataract: an epidemiologic perspective. Surv Ophthalmol 1986; 31(3)175–84
- Chylack L T., Jr, Leske M C, Sperduto R, Khu P, McCarthy D, LOCS Research Group. Lens opacities classification system. Arch Ophthalmol 1988; 106: 330–4
- Taylor H R. The epidemiology and public health significance of cataract blindness. Curr Asp Ophthalmol 1992; 17–21
- West S K. Who develops cataracts?. Arch Ophthalmol 1991; 109: 196–7
- US Department of Health, Education and Welfare. Plan and operation of the Health and Nutrition Examination Survey. DHEW, Rockville 1973, United States 1971-3. PHS Publication No. (HSM) 73 -1310, Series 1, Nos. 10a end 10b
- Leibowitz H M, Krueger D E, Maunder L R, Milton R C, Kini M M, Kahn H A. The Framingham Eye Study monograph. Surv Ophthalmol 1980; 24(suppl)335–610
- Goldstein H. The reported demography and causes of blindness throughout the world. Adv Ophthalmol 1980; 40: 1–99
- Cullman T. Visual Disability in the Elderly. Croon Helm, London 1986
- Sommer A. Epidemiology of eye disease. Epidemiol Rev 1991; 11: 236–40
- Klein B EK, Klein R. Cataracts and macular degeneration in older Americans. Arch Opthalmol 1982; 100: 571–3
- Kahn H A, Leibowitz H M, Ganley J P, Kini M M, Colton T, Nickerson R S, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977; 106(1)17–32
- Kahn H A, Leibowitz H M, Ganley J P, Kini M M, Colton T, Nickerson R S, et al. The Framingham Eye Study. 11. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977; 106(1)33–41
- Roberts J, Ludford J. Monocular visual acuity of persons 4-74 years. US Department of Health, Education and Welfare, Rockville 1977, United States 1971-2. PHS Publication No. (HRA) 77-1646. Vital Health Stat. 11, No. 201
- Ederer F, Hiller R, Taylor H R. Senile lens changes and diabetes in two population studies. Am J Ophthalmol 1981; 91: 381–5
- Sommer A, Tielsch J M, Katz J, Quigley H A, Gottsch J D, Javitt J C, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med 1991; 325: 1412–7
- Gibson J M, Rosenthal A R, Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 1985; 104: 196–203
- Martinez G S, Campbell A J, Reinken J, Allan B C. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 1982; 94: 181–9
- Young R W. Age-related cataract. Oxford University Press, New York 1991
- Kupfer C. The conquest of cataract: a global challenge. Trans Ophthalmol Soc UK 1984; 104: 1–10
- Brilliant L B, Grasset N C, Pokhrel R P, Kolstad A, Lepowski J M, Brilliant G E, et al. Associations among cataract prevalence, sunlight hours, and altitude in the Himalayas. Am J Epidemiol 1983; 118(2)250–64
- Duke-Elder W S. The pathological action of light upon the eye. Lancet 1926; 1: 1188–91
- Hiller R, Sperduto R D, Ederer F. Epidemiologic associations with cataract in the 1971-72 National Health and Nutrition Examination Survey. Am J Epidemiol 1983; 118: 239–49
- Hollows F, Moran D. Cataract - the ultraviolet risk factor. Lancet 1981; 2: 1249–50
- Taylor H R. The environment and the lens. Br J Ophthalmol 1980; 64: 303–10
- Zigman S, Datiles M, Torczynski E. Sunlight and human cataracts. Invest Ophthalmol Vis Sci 1979; 18: 462–7
- Hiller R, Giacometti L, Yuen K. Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol 1977; 105(5)450–9
- Dolezal J M, Perkins E S, Wallace R B. Sunlight, skin sensitivity, and senile cataract. Am J Epidemiol 1989; 129(3)559–68
- Collman G W, Shore D L, Shy C M, Checkoway H, Luira A S. Sunlight and other risk factors for cataracts: an epidemiologic study. Am J Public Health 1988; 78(11)1459–62
- Miranda M N. Environmental temperature and senile cataracts. Trans Am Ophthalmol Soc 1980; 78: 255–62
- Evans J, Minassian D C. Epidemiology of age-related cataract. Comm Eye Health 1992; 3–6
- Rothman K J. Modern Epidemiology. Little Brown & Co, Boston 1986
- Bochow T W, West S K, Azar A, Munoz B, Sommer A, Taylor H R. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol 1989; 107: 369–72
- Mohan M, Sperduto R D, Angra S K, Milton R C, Mathur R L, Underwood B A, et al. India-US case-control study of age-related cataracts. Arch Ophthalmol 1989; 107: 670–6
- Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991; 133: 541–53
- Leske M C, Chylack L T, Jr, Wu S-Y, the Lens Opacities Case-control Study Group. The lens opacities case-control study Risk factors for cataract. Arch Ophthalmol 1991; 109: 244–51
- Bunce G E, Kinoshita J, Horwitz J. Nutritional factors in cataract. Ann Rev Nutr 1990; 10: 23–54
- Jacques P F, Chylack L T, McGandy R B, Hartz S C. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1986; 108: 337–40
- Sperduto R D, Ferris F L, III, Kurinij F L. Do we have a nutritional treatment for age-related cataract or macular degeneration?. Arch Ophthalmol 1990; 108: 1403–5
- Maraini G, Pasquini P, Sperduto R D, Rosmini F, Bonacini M, Tomba M C, et al. Distribution of lens opacities in the Italian-American case-control study of age-related cataract. Ophthalmology 1990; 97: 752–6
- Taylor A. Role of nutrients in delaying cataracts. Ann NY Acad Sci 1992; 573: 111–124
- Robertson J M, Donner A P., Trevthick J R. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 1989; 570: 372–82
- Hankinson S E, Stampfer M J, Seddon J M, Colditz G A, Rosner B, Speizer F E, et al. Nutrient intake and cataract extraction in women: a prospective study. Br Med J 1992; 305: 335–9
- Sperduto R D, Hu T-S, Milton R C, Zhao J-L, Everett D F, Chang Q-F, et al. The Linxian cataract studies. Arch Ophthalmol 1993; 111: 1246–53
- Vitale S, West S, Hallfrisch J, Alston C, Wang F, Moorman C, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993; 4: 195–203
- Koplan J P, Annest J L, Layde P M, Rubin G L. Nutritional intake and supplementation in the United States (NHANES II). Am J Public Health 1986; 76: 287–9
- Minassian D C, Mehra V, Jones B R. Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet 1984; 1: 751–7
- Minassian D C, Mehra V, Verrey J-D. Dehydrational crises: a major risk factor in blinding cataract. Br J Ophthalmol 1989; 73: 100–5
- Bhatnager R, West K P, Vitale S, Sommer A, Joshi S, Venkataswamy G. Risk of cataract and history of severe diarrhoeal disease in Southern India. Arch Ophthalmol 1991; 109: 696–9
- Van Heyningen R, Harding J. A case-control study of cataract in Oxfordshire: some risk factors. Br J Ophthalmol 1988; 72: 804–8
- Taylor H R, Munoz B. Risk factors for cataract Correspondence to the editor. Brit J Ophthalmol 1989; 73: 579
- Black R L, Oglesby R B, von Sallman L, et al. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960; 174: 150–55
- Skalka H W, Prchal J T. Effect of corticosteroids on cataract formation. Arch Ophthalmol 1980; 98: 1773–7
- Harding J J, Van Heyningen R. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 1988; 72: 809–14
- Lerman S, Megaw J M, Fardner K. Allopurinol therapy and cataractoge-nesis in humans. Am J Ophthalmol 1982; 94: 141–6
- Lerman S, Megaw J, Fraunfelder F T. Further studies of allopurinol therapy and human cataractogenesis. Am J Ophthalmol 1984; 97: 205–9
- Clayton R M, Cuthbert J, Phillips C I, Bartholomew R S, Stokoe N L, Ffytche T, et al. Analysis of individual cataract patients and their lenses: a progress report. Exp Eye Res 1980; 31: 553–66
- Milne M, Williamson J. Visual acuity in older people. Geront Clin 1972; 14: 249–56
- Linton K LP, Klein B EK, Klein R. The association between posterior subcapsular cataract and the use of antihypertensive and diuretic medications. SERabstracts 1991; 759
- Gibson J M, Shaw D E, Rosenthal A R. Senile cataract and senile macular degeneration: an investigation into possible risk factors. Trans Ophthalmol Soc UK 1986; 105: 463–8
- Bartholomew R S, Clayton R M, Cuthbert J, Duffy J, Phillips C I, Reid Mc K, (1980) Analysis of individual cataract patients and their lenses: preliminary observations on a population basis. Ageing of the Lens. Proceedings of the Symposium on Ageing of the Lens held in Paris. Sept., 29-301979, F Regnault, O Hockwin, Y Courtois, et al. Elsevier/North Holland Biomedical Press, Amsterdam, 241–61
- Isaac N E, Walker A M, Hershel J, Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol 1991; 109: 255–60
- West S K, Munoz B, Emmett E A, Taylor H R. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989; 107: 1166–9
- Flaye D E, Sullivan K N, Cullinan T R, Silver J H, Whitlocke R AF. Cataract and cigarette smoking. Eye 1989; 3: 379–84
- Clayton R, Cuthbert J, Duffy J, Seth J, Phillips C I, Bartholomew R S, et al. Some risk factors associated with cataract in SE Scotland: a pilot study. Eye 1982; 102: 331–36
- Klein B EK, Klein R, Moss S E. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985; 92: 1191–6
- Schectman G, Byrd J C, Gruchow H W. The influence of smoking on vitamin C status in adults. Am J Public Health 1989; 579: 158–62
- Russel-Briefel R, Bates M W, Kuller L. The relationship of plasma carotenoids to health and biological factors in middle-aged men. Am J Epidemiol 1985; 122: 741–9
- Munoz B, Tajchman U, Bochow T, West S. Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol 1993; 111: 110–2
- Ritter L L, Klein B EK, Klein R, Mares-Periman J A. Alcohol use and lens opacities in the Beaver Dam Study. Arch Ophthalmol 1993; 111: 113–7
- Rao G N, Lardis M P, Cotlier E. Acetylation of lens crystallins: a possible mechanism by which aspirin could prevent cataract formation. Biochem Biophys Res Commun 1985; 128: 125–32
- Kinoshita J H, Fukushi S, Kador H N. Aldose reductase in diabetic complications of the eye. Metabolism 1979; 28: 462–9
- Kinoshita J H. Mechanisms initiating cataract formation. Invest Ophthalmol 1974; 13: 713–24
- Harding J J, Egerton M, Harding R S. Protection against cataract by aspirin, paracetamol and ibuprofen. Acta Ophthalmol 1989; 67: 518–24
- Chen T T., Hockwin O, Dobbs R, Knowles W, Eckerskarn U. Cataract and health status: a case-control study. Ophthalmic Res 1988; 20: 1–9
- Klein B EK, Klein R, Moss S E. Is aspirin use associated with lower rates of cataracts in diabetic individuals. Diabetes Care 1987; 10: 495–9
- West S K, Munoz B E, Newland H S, et al. Lack of evidence for aspirin use and prevention of cataracts. Arch Ophthalmol 1987; 105(9)1229–31
- Walker A M, Jick H, Gorman M R, et al. Steroids, diabetes, analgesics, and the risk of cataract: lessons learnt from the epidemiology of cataract extraction. J Clin Res Drug Develop 1988; 2: 227–32
- Seddon J M, Christen W G, Manson J E, Buring J E, Sperduto R D, Hennekens C H. Low dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol 1991; 109: 252–5
- Cheng H. Aspirin and cataract. Editorial. Br J Ophthalmol 1992; 76: 257–8
- McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. International Diabetes Institute, MelbourneAustralia 1994
- Kinoshita J H. Aldose reductase in the diabetic eye XLIII Edward Jackson Memorial Lecture. Am J Ophthalmol 1986; 102(6)685–2
- Skalka H W, Prchal J T. The effect of diabetes mellitus and diabetic therapy on cataract formation. Ophthalmology 1981; 88: 117–24
- Gourlay S G, Hill D J. Smoking cessation strategies. A textbook of preventive medicine, J J McNeil, R WF King, G L Jennings, et al. Edward Arnold, Australia 1990; 157–69
- Sewell R B, Marshall A W. Alcohol. Individual abuse, community responsibility. A textbook of preventive medicine, J J McNeil, R WF King, G L Jennings, et al. Edward Arnold, Australia 1990; 191–203
- Shaffer R N, Rosenthal G. Comparison of cataract incidence in a normal vs a glaucomatous population. Trans Am Ophthalmol Soc 1969; 67: 369–73
- Cataracts kept at bay by vitamins. (Editorial). Thorax 1993; 48: 879–91
- McNeil J J, Taylor H R, Silagy C., Prevention of cataract in the elderly by low dose aspirin and vitamin E. Public Health & Research Development Committee No. 944610